Depression is a widespread mental health disorder affecting around 3.8% of the global population, including 5% of adults, 4% among people assigned male at birth (AMAB) and 6% among people assigned female at birth(AFAB), and 5.7% of individuals over the age of 60. Globally, approximately 280 million people live with depression.1 This term serves as an umbrella for various subtypes, including major depressive disorder, persistent depressive disorder, and premenstrual dysphoric disorder, each marked by profound and persistent feelings of sadness, emptiness, or irritability. These emotional struggles are often accompanied by cognitive and physical symptoms, such as difficulty concentrating, sleep disruptions, appetite changes, fatigue, and unexplained aches, all of which can impede daily functioning. These symptoms, including difficulty concentrating, changes in sleep patterns, altered appetite, and physical complaints such as fatigue or unexplained aches, can vary in intensity and presentation from one person to another 2
The presentation of symptoms can range widely - some individuals may experience a few mild symptoms, while others endure a multitude of severe symptoms, highlighting the complex, multifaceted nature of depression. Generally, depression progresses through stages, from initial sadness to mild depression, then clinical depression, and finally, in severe cases, suicidal ideation. Given this range, depression is recognised as a challenging condition to manage, necessitating individualised treatment approaches that reflect its spectrum of severity and impact on daily life.
Risk factors influencing depression
There are biological, genetic, environmental, and psychological elements that play a significant role in the development of depression. Those with a family history of depression, major life stressors, or chronic illnesses like diabetes or heart disease often face a higher risk of developing depression. Depression is of particular concern in middle-aged and older adults, where it frequently coexists with serious medical illnesses, further complicating both conditions and heightening the importance of effective treatments.
Additionally, individuals from historically marginalised communities, such as LGBTQI+ populations, show higher rates of depression, partly due to social stressors and stigma.3 Individuals AMAB, while less frequently diagnosed than those AFAB, are more likely to experience undiagnosed or untreated depression, possibly because they may recognise or express their symptoms differently, often through irritability or substance abuse.
The endocannabinoid system and depression treatment
The endocannabinoid system - a crucial network within the body responsible for regulating mood and stress responses- has emerged as a potential target for treatment. This system's involvement in emotional regulation has led researchers to explore the use of cannabis as a potential adjunct to traditional depression treatments. But how well cannabis alleviates symptoms of depression may depend not only on the compounds themselves but also on an individual's lifestyle habits and overall health. Factors such as diet, exercise, sleep quality, and stress management have been shown to influence how the body processes substances and, in turn, their efficacy. Given the variability in how depression presents and impacts individuals, understanding the influence of lifestyle factors on treatment outcomes is vital for people considering cannabis as part of a holistic approach to manage the symptoms of their depression.4
Current research on cannabis and depression
Although the use of cannabis for treating depressive symptoms has garnered significant attention recently, existing systematic reviews and clinical research suggest limited evidence supporting its efficacy in improving depressive symptoms. The most recent quality review by Whiting et al. (2015) analysed five randomised controlled trials (RCTs) involving 634 participants with chronic pain or multiple sclerosis who were also experiencing mild depressive symptoms. This review focused on trials using various cannabis-based medications such as nabiximols, dronabinol, and nabilone, comparing them to placebos over a period of 8 hours to 9 weeks. However, the findings were largely inconclusive, as none of the trials found a significant positive impact on depressive symptoms, and one trial even noted increased depressive symptoms at higher doses of nabiximols. The studies were also compromised by a high risk of bias, and the results showed no difference in depressive outcomes when comparing nabilone to an alternative medication, dihydrocodeine.5
This highlights just how early the research is on using cannabis to treat depression. Although cannabis has garnered attention for its potential to relieve depressive symptoms, findings so far are mixed and inconclusive, particularly as its effects can vary significantly from person to person. Future research focusing on how lifestyle factors impact the efficacy of cannabis used in the treatment of depression, specifically, is essential. As research progresses, understanding these nuances will be crucial to safely and effectively incorporating cannabis into broader treatment strategies for depression.
The complex relationship between cannabis use and depression
Beyond systematic reviews, observational and epidemiological studies have noted a high prevalence of cannabis use among individuals with depression, with some studies suggesting that cannabis may exacerbate depressive symptoms rather than alleviate them. For instance, research has demonstrated a link between non-medical cannabis use and poorer mental health outcomes, including severe psychiatric symptoms, increased rates of suicidal ideation, and lower utilisation of mental health services. Such findings raise concerns about the clinical implications of cannabis use in depressive populations, especially given that people with depressive symptoms may turn to cannabis as a self-management strategy despite its unproven efficacy and potential for adverse effects. This research highlights the importance of ensuring controlled, prescribed use of cannabis to alleviate symptoms of depression, to ensure safe composition and controlled dosage of the medication.6
The role of lifestyle in enhancing cannabis efficacy
Lifestyle factors, such as diet, sleep quality, and physical activity, can significantly influence the effectiveness of cannabis in treating depression. Studies indicate that poor lifestyle habits may counteract the potential benefits of cannabis-based treatments. For instance, sleep quality is crucial; disruptions in sleep can worsen depressive symptoms and potentially reduce the efficacy of cannabis, particularly if used to manage mood disorders. Similarly, nutrition and exercise can impact the body’s endocannabinoid system, which is associated with mood regulation and the action of cannabinoids, suggesting that balanced nutrition and regular physical activity could enhance the antidepressant effects of cannabis compounds.
Key lifestyle factors affecting cannabis efficacy
- Diet and nutrition: How nutrients influence the endocannabinoid system and the processing of cannabis compounds, with examples like omega-3 fatty acids
- Physical activity: Exercise’s impact on mood and mental health, including its interactions with cannabis's effects on endorphins and neurotransmitters
- Sleep patterns: Quality and consistency of sleep affect mood regulation and how cannabis impacts sleep cycles, particularly in people with depression
- Stress management: The role of chronic stress on endocannabinoid receptors and how practices like mindfulness may complement cannabis for better outcomes
Lifestyle recommendations
For individuals using cannabis to help manage depression, incorporating healthy lifestyle habits can help optimise potential benefits. A balanced lifestyle that includes a nutritious diet, regular physical activity, and effective stress management techniques can support mental health and may amplify the mood-stabilising effects of cannabis. Nutrient-dense foods can nourish the brain, enhancing neurotransmitter function and supporting the endocannabinoid system, while physical activity promotes the release of mood-lifting endorphins. Managing stress through techniques like mindfulness, meditation, or yoga may help regulate cortisol levels, which, in turn, supports mood stability and can improve sleep patterns- key factors in depression management.
Given the complexity of depression and individual responses to treatment, consulting with healthcare professionals is vital. They can help create a tailored plan that integrates cannabis with lifestyle modifications and, if needed, conventional treatments. This individualised approach allows for safe monitoring of cannabis use, reducing risks and optimising therapeutic benefits.
FAQs
What is the relationship between cannabis use and depression?
Cannabis is often considered for its potential to alleviate depressive symptoms; however, research shows mixed results. While some individuals report relief, others may experience exacerbated symptoms, highlighting the complexity of its effects.
How do lifestyle factors influence the efficacy of cannabis in treating depression?
Lifestyle factors such as diet, physical activity, sleep quality, and stress management significantly impact how cannabis interacts with the body and its potential therapeutic effects. A balanced lifestyle may enhance the benefits of cannabis treatment.
Can exercise improve the effectiveness of cannabis in managing depression?
Yes, regular physical activity can elevate mood and enhance mental health by promoting the release of endorphins. Exercise can work synergistically with cannabis to provide better mood stabilisation.
Is it safe to self-medicate with cannabis for depression?
Self-medicating can pose risks, particularly without professional guidance. Consulting healthcare providers can ensure safe monitoring of cannabis use and integration with lifestyle modifications and conventional treatments.
What should individuals consider before using cannabis for depression?
Individuals should evaluate their overall health, lifestyle habits, and potential interactions with other treatments. A tailored approach, guided by a healthcare professional, is essential for effective management of depression.
Summary
While cannabis may offer potential benefits for managing depressive symptoms, a holistic approach that includes lifestyle factors is essential. Proper diet, regular exercise, and stress management can support the therapeutic effects of cannabis. Self-medicating, however, carries risks, especially in the absence of professional guidance. Integrating cannabis with traditional treatments and lifestyle adjustments under medical supervision can provide a balanced and safer path to managing depression.
References
- World Health Organization. Depressive disorder (depression) [Internet]. World Health Organization. World Health Organization; 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/depression.
- Chand S, Arif H. Depression [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430847/.
- Puckett JA, Dyar C, Maroney MR, Mustanski B, Newcomb ME. Daily experiences of minority stress and mental health in transgender and gender-diverse individuals. Journal of Psychopathology and Clinical Science. 2023 Mar 13;
- Sharafi A, Pakkhesal S, Fakhari A, Khajehnasiri N, Ahmadalipour A. Rapid treatments for depression: Endocannabinoid system as a therapeutic target. Neuroscience & Biobehavioral Reviews. 2022 Jun;137:104635.
- National Academies of Sciences, Engineering, and Medicine. Therapeutic Effects of Cannabis and Cannabinoids [Internet]. Nih.gov. National Academies Press (US); 2017. Available from: https://www.ncbi.nlm.nih.gov/books/NBK425767/.
- Feingold D, Weinstein A. Cannabis and Depression. Cannabinoids and Neuropsychiatric Disorders. 2020 Dec 18;1264:67–80.

